首页> 外国专利> REMOVAL OF TARGET CELLS BY CIRCULATING VIRUS-SPECIFIC CYTOTOXIC T-CELLS USING MHC CLASS I COMPRISING COMPLEXES.

REMOVAL OF TARGET CELLS BY CIRCULATING VIRUS-SPECIFIC CYTOTOXIC T-CELLS USING MHC CLASS I COMPRISING COMPLEXES.

机译:使用包含复合物的I类MHC通过循环病毒特异性细胞毒性T细胞来去除靶细胞。

摘要

Herein is reported a complex comprising as first part an antibody derived part that specifically binds to a target antigen, and as second part a virus-derived peptide linked to a MHC class I protein complex. With the complex as reported herein existing virus-specific circulating cytotoxic T-cells (T-memory-cells or T-effector-cells) of an individual can be directed to cells expressing the target antigen, to which the antibody derived part of the covalent complex specifically binds to, by dressing these cells with a MHC class I complexes mimicking an acute viral infection. Thus, one aspect as reported herein is a complex, characterized in that it comprises one fusion polypeptide that comprises in N- to C-terminal direction either (i) a β2-microglobulin, and (ii) the extracellular domains α1, α2, and α3 of a class I MHC molecule with a relative frequency of less than 1 %, or (i) a virus- derived peptide, (ii) a β2-microglobulin, and (iii) the extracellular domains α1, α2, and α3 of a class I MHC molecule with a relative frequency of 1 % or more, and two polypeptide chains, which are linked by one or more disulfide bonds, wherein the first disulfide-linked polypeptide chain comprises in N- to C-terminal direction (i) an immunoglobulin light or heavy chain variable domain, (ii) an immunoglobulin light or heavy chain constant domain, and (iii) an antibody heavy chain hinge region polypeptide, and the second disulfide-linked polypeptide chain comprises an antibody heavy chain hinge region polypeptide, wherein the fusion polypeptide is either covalently bound either to the C-terminus or the N-terminus of one of the disulfide-linked polypeptide chains, or covalently bound to the N-terminus of an antibody variable domain that is the complementary heavy or light chain variable domain to that comprised in the first disulfide-linked polypeptide chain.
机译:本文报道了一种复合物,其包括作为第一部分的与靶抗原特异性结合的抗体衍生部分,以及作为第二部分的与MHC I类蛋白复合物连接的病毒衍生肽。利用本文报道的复合物,可以将个体的现有病毒特异性循环细胞毒性T细胞(T记忆细胞或T效应细胞)导向表达靶抗原的细胞,抗体衍生的共价部分通过用模仿急性病毒感染的MHC I类复合物包被这些细胞,该复合物特异性结合。因此,本文报道的一个方面是一个复杂的方面,其特征在于它包含一种融合多肽,该融合多肽在N端至C端方向包含(i)β2-微球蛋白和(ii)细胞外域α1,β I类MHC分子的相对频率小于1%的±2和γ3,或(i)病毒衍生的肽,(ii)β2-微球蛋白,和(iii)细胞外域α I类MHC分子的相对频率为1%或更高的1,α2和α3,以及两个多肽链,它们通过一个或多个二硫键相连,其中第一条与二硫键相连的多肽链包括在N端到C端方向(i)免疫球蛋白轻链或重链恒定域,(ii)免疫球蛋白轻链或重链恒定域,和(iii)抗体重链铰链区多肽,第二个二硫键连接多肽链包含抗体重链铰链区多肽,其中融合多肽是共价的y结合至二硫键连接的多肽链之一的C端或N端,或共价结合至抗体可变域的N端,该抗体可变域是与包含在其中的抗体互补的重链或轻链可变域第一条二硫键连接的多肽链。

著录项

  • 公开/公告号MX2013014869A

    专利类型

  • 公开/公告日2014-03-31

    原文格式PDF

  • 申请/专利权人 F. HOFFMANN-LA ROCHE AG;

    申请/专利号MX20130014869

  • 发明设计人 HENDRIK KNOETGEN;

    申请日2012-06-19

  • 分类号C07K16/46;A61K47/48;C07K14/705;C07K16/28;

  • 国家 MX

  • 入库时间 2022-08-21 15:57:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号